SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001188112-14-000562
Filing Date
2014-03-03
Accepted
2014-03-03 17:18:13
Documents
5
Group Members
DANIEL J. DONOGHUEDISCOVERY EQUITY PARTNERS, L.P.MICHAEL R. MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 7) t78511_sc13da.htm SC 13D/A 128036
2 EXHIBIT 1 ex_1.htm EX-1 41678
3 EXHIBIT 2 ex_2.htm EX-2 11656
4 EXHIBIT 3 ex_3.htm EX-3 14338
5 EXHIBIT 4 ex_4.htm EX-4 14477
  Complete submission text file 0001188112-14-000562.txt   211793
Mailing Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 (312) 265-96000
Discovery Group I, LLC (Filed by) CIK: 0001312548 (see all company filings)

IRS No.: 300075077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 520 LAKE COOK ROAD SUITE 520 DEERFIELD IL 60062
Business Address 520 LAKE COOK ROAD SUITE 520 DEERFIELD IL 60062 224-383-3000
HORIZON PHARMA, INC. (Subject) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86365 | Film No.: 14661491
SIC: 2834 Pharmaceutical Preparations